• Je něco špatně v tomto záznamu ?

Toxicity of carboxylated carbon nanotubes in endothelial cells is attenuated by stimulation of the autophagic flux with the release of nanomaterial in autophagic vesicles

M. Orecna, SH. De Paoli, O. Janouskova, TZ. Tegegn, M. Filipova, JE. Bonevich, K. Holada, J. Simak,

. 2014 ; 10 (5) : 939-48.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/bmc15014501

UNLABELLED: Carbon nanotubes (CNTs) exhibit a number of unique properties that make them attractive for various nanomedicine applications including their intravascular use. Therefore, the vascular toxicity of CNTs is a critical safety concern and methods of CNTs toxicity modulation are of great interest. Here, we report that carboxylated multiwalled carbon nanotubes (MWCNTs) induce a decrease in viability of cultured human umbilical vein endothelial cells (HUVECs) associated with the profound accumulation of autophagosomes. This autophagosome accumulation was mTOR kinase independent and was caused by blockade of the autophagic flux rather than by activation of autophagy. Stimulation of the autophagic flux with 1nmol/L bafilomycin A1 attenuated the cytotoxicity of carboxylated MWCNTs in HUVECs and was associated with the extracellular release of the nanomaterial in autophagic microvesicles. Thus, pharmacological stimulation of the autophagic flux may represent a new method of cytoprotection against toxic effects of nanomaterials. FROM THE CLINICAL EDITOR: This study investigates the mechanisms of toxicity of multiwalled carbon nanutubes on human endothelial cells, concluding that pharmacological stimulation of autophagic flux may represent a new method of cytoprotection against the toxic effects of these nanomaterials.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014501
003      
CZ-PrNML
005      
20150428113711.0
007      
ta
008      
150420s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.nano.2014.02.001 $2 doi
035    __
$a (PubMed)24566271
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Orecna, Martina $u Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD, USA.
245    10
$a Toxicity of carboxylated carbon nanotubes in endothelial cells is attenuated by stimulation of the autophagic flux with the release of nanomaterial in autophagic vesicles / $c M. Orecna, SH. De Paoli, O. Janouskova, TZ. Tegegn, M. Filipova, JE. Bonevich, K. Holada, J. Simak,
520    9_
$a UNLABELLED: Carbon nanotubes (CNTs) exhibit a number of unique properties that make them attractive for various nanomedicine applications including their intravascular use. Therefore, the vascular toxicity of CNTs is a critical safety concern and methods of CNTs toxicity modulation are of great interest. Here, we report that carboxylated multiwalled carbon nanotubes (MWCNTs) induce a decrease in viability of cultured human umbilical vein endothelial cells (HUVECs) associated with the profound accumulation of autophagosomes. This autophagosome accumulation was mTOR kinase independent and was caused by blockade of the autophagic flux rather than by activation of autophagy. Stimulation of the autophagic flux with 1nmol/L bafilomycin A1 attenuated the cytotoxicity of carboxylated MWCNTs in HUVECs and was associated with the extracellular release of the nanomaterial in autophagic microvesicles. Thus, pharmacological stimulation of the autophagic flux may represent a new method of cytoprotection against toxic effects of nanomaterials. FROM THE CLINICAL EDITOR: This study investigates the mechanisms of toxicity of multiwalled carbon nanutubes on human endothelial cells, concluding that pharmacological stimulation of autophagic flux may represent a new method of cytoprotection against the toxic effects of these nanomaterials.
650    _2
$a autofagie $x fyziologie $7 D001343
650    _2
$a endoteliální buňky $x účinky léků $x metabolismus $7 D042783
650    _2
$a exocytóza $x účinky léků $7 D005089
650    _2
$a endoteliální buňky pupečníkové žíly (lidské) $7 D061307
650    _2
$a lidé $7 D006801
650    _2
$a makrolidy $x farmakologie $7 D018942
650    _2
$a nanostruktury $x toxicita $7 D049329
650    12
$a nanotrubičky uhlíkové $7 D037742
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
655    _2
$a Research Support, U.S. Gov't, P.H.S. $7 D013487
700    1_
$a De Paoli, Silvia H $u Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD, USA.
700    1_
$a Janouskova, Olga $u Institute of Immunology and Microbiology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic; Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Prague Czech Republic.
700    1_
$a Tegegn, Tseday Z $u Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD, USA.
700    1_
$a Filipova, Marcela $u Institute of Immunology and Microbiology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Bonevich, John E $u National Institute of Standards and Technology, Gaithersburg, MD, USA.
700    1_
$a Holada, Karel $u Institute of Immunology and Microbiology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
700    1_
$a Simak, Jan $u Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD, USA. Electronic address: jan.simak@fda.hhs.gov.
773    0_
$w MED00167284 $t Nanomedicine nanotechnology, biology, and medicine $x 1549-9642 $g Roč. 10, č. 5 (2014), s. 939-48
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24566271 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20150428114014 $b ABA008
999    __
$a ok $b bmc $g 1072082 $s 897379
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 10 $c 5 $d 939-48 $i 1549-9642 $m Nanomedicine $n Nanomedicine $x MED00167284
LZP    __
$a Pubmed-20150420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...